Psychotic disorders, eating habits, and physical activity: Who is ready for lifestyle changes?

Psychiatric Services

Volumn 58, Issue 2, 2007, Pages 233-239

  Archie, Suzanne M ^a,c   Goldberg, Joel O ^a   Akhtar Danesh, Noori ^a   Landeen, Janet ^a   McColl, Linda ^b   McNiven, Jean ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Homewood Health Centre Guelph   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; BODY IMAGE; BODY MASS; CONTROLLED STUDY; DIETARY INTAKE; EATING HABIT; FEMALE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREVALENCE; PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; SIDE EFFECT; THEORETICAL MODEL; WEIGHT GAIN;

EID: 33847417457     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.2007.58.2.233     Document Type: Article

References (45)

1. Simpson MM, Goetz RR: Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods. Journal of Clinical Psychiatry 62:694-700, 2001
2. Allison DB, Mentore JL, Heo M, et al: Antipsychotic-induced weight gain: a comprehensive research synthesis. American Journal of Psychiatry 156:1686-1696, 1999
3. Freedman R: The choice of antipsychotic drugs for schizophrenia. New England Journal of Medicine 353:1286-1288, 2005
4. Lieberman J, Stroup T, McEvoy J, et al: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353:1209-1223, 2005
5. Sachs GS, Guille G: Weight gain associated with use of psychotropic medications. Journal of Clinical Psychiatry 60(suppl 21):16-19, 1999
6. Green A, Patel J, Goisman R, et al: Weight gain from novel antipsychotic drugs: need for action. General Hospital Psychiatry 22:224-235, 2000
7. Kendrick T: Cardiovascular and respiratory risk factors and symptoms among general practice patients with long term mental illness. British Journal of Psychiatry 169:733-739, 1996
8. Sernyak MJ, Leslie DL, Losonczy MF, et al: Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. American Journal of Psychiatry 159:561-566, 2003
9. Allison DB, Fontaine KR, Heo M, et al: The distribution of body mass index among individuals with and without schizophrenia. Journal of Clinical Psychiatry 60:220, 1999
10. Byrne AE, Byrne DG: The effect of exercise on depression, anxiety, and other mood states: a review. Journal of Psychosomatic Research 37:565-574, 1993
11. Koller E, Schneider B, Bennett K, et al: Clozapine-associated diabetes. American Journal of Medicine 111:716-723, 2001
12. Coldham EL, Addington J, Addington D: Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica 106:286-290, 2002
13. Archie S, Hamilton Wilson J, et al: Pilot study: access to fitness facility and exercise levels in olanzapine treated patients. Canadian Journal of Psychiatry 48:355-359, 2003
14. Marcus T, Rakowski W, Ross J: Assessing motivational readiness and decision-making for exercise. Health Psychology 11:257-261, 1992
15. Marcus T, Rossi J, Selby V, et al: The stages and processes of exercise adoption and maintenance in a worksite sample. Health Psychology 11:386-395, 1992
16. Marcus GH, Banspach SW, Levebvre RC, et al: Using the stages of change model to increase the adoption of physical activity among community participants. American Journal of Health Promotion 6:424-429, 1992
17. Woods C, Murrie N, Scott M: Physical activity intervention: a Transtheoretical-Model-based intervention designed to help sedentary young adults become active. Health Education Research 17:451-160, 2002
18. Dallow CB, Anderson J: Using self-efficacy and a transtheoretical model to develop a physical activity intervention for obese women. American Journal of Health Promotion 17:373-381, 2003
19. Young DR, King AC, Sheehan M, et al: Stage of motivational readiness: predictive ability for exercise behavior. American Journal of Health Behavior 26:331-341, 2002
20. Hallam JS, Petosa R: The long-term impact of a four-session work-site intervention on selected social cognitive theory variables linked to adult exercise adherence. Health Education and Behavior 31:88-100, 2004
21. Zimmerman GL, Olsen CG, Bosworth M: A "stages of change" approach to helping patients change behavior. American Family Physician 61:1409-1416, 2000
22. Kemp R, Hayward P, Applewhaite G, et al: Compliance therapy in psychotic patients: a randomized controlled trial. British Medical Journal 312:345-349, 1996
23. Steinberg M, Ziedonis D, Krejci J, et al: Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. Journal of Consulting and Clinical Psychology 72:723-728, 2004
24. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994
25. Long BJ, Calfas KJ, Sallis JF, et al: A multi-site field test of the acceptability of physical activity counseling in primary care: Project PACE. American Journal of Preventive Medicine 12:73-81, 1996
26. Patrick K, Sallis J, Calfas KJ, et al: Physical activity, in PACE: Patient-Centered Assessment and Counseling for Exercise and Nutrition. Edited by Caparosa S, Thompson S. San Diego, San Diego State University Foundation, San Diego Center for Health Interventions, 2001
27. Reboussin BA, Rejeski W, Martin KA, et al: Correlates of satisfaction with body function and body appearance in middle- and older aged adults: the Activity Counseling Trial (ACT). Psychology and Health 15:239-254, 2000
28. Godin G, Shephard RJ: A simple method to assess exercise behaviour in the community. Canadian Journal of Applied Sport Sciences 10:141-146, 1985
29. Block G, Gillespie C, Rosenbloom EH, et al: A rapid food screener to assess fat and fruit and vegetable intake. American Journal of Preventive Medicine 18:284-288, 2000
30. Smucker R, Block G, Coyle L, et al: A dietary and risk factor questionnaire and analysis system for personal computers. American Journal of Epidemiology 129:445-449, 1989
31. Statistics Canada: Health Indicators. Catalogue no 82-221. Canadian Community Health Survey, June 2004. Available at www.statcan.ca
32. BHF Coronary Heart Disease Statistics. London, British Heart Foundation, 2003
33. Goldberg JO, Moll S, Washington A: Exploring the challenge of tobacco use and schizophrenia. Psychiatric Rehabilitation Skills 1:51-63, 1996
34. Etter M, Mohr S, Garin C, et al: Stages of change in smokers with schizophrenia or schizoaffective disorder and in the general population. Schizophrenia Bulletin 30:459-468, 2004
35. Peet M: Diet, diabetes, and schizophrenia. British Journal of Psychiatry 184(suppl 47):s102-s105, 2004
36. McCreadie R: Diet, smoking, and cardiovascular risk in people with schizophrenia. British Journal of Psychiatry 183:534-539, 2003
37. Blin O, Micallef J: Antipsychotic-associated weight gain and clinical outcome parameters. Journal of Clinical Psychiatry 62(suppl 7):11-21, 2001
38. Callaghan P: Exercise: a neglected intervention in mental health care? Journal of Psychiatric and Mental Health Nursing 11:476-483, 2004
39. Bushe C, Haddad P, Peveler R, et al: The role of lifestyle interventions and weight management in schizophrenia. Journal of Psychopharmacology 19:28-35, 2005
40. Menza M, Vreeland B, Minsky S, et al: Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. Journal of Clinical Psychiatry 65:471-477, 2004
41. Vreeland B, Minsky S, Menza M, et al: A program for managing weight gain associated with atypical antipsychotics. Psychiatric Services 54:1155-1157, 2003
42. Wirshing DA, Wirshing WC, Kysar L, et al: Novel antipsychotics: comparisons of weight gain liabilities. Journal of Clinical Psychiatry 60:358-363, 1999
43. Ball PM, Coons V, Buchannan R: A weight management program for treatment of olanzapine-related weight gain. Psychiatric Services 52:967-969, 2001
44. Rusch N, Corrigan PW: Motivational interviewing to improve insight and treatment adherence in schizophrenia. Psychiatric Rehabilitation Journal 26:23-32, 2002
45. Barrowclough C, Haddock G, Tarrier N, et al: Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry 158:1706-1713, 2001